key: cord-1055387-n9bg2i98
authors: Guo, Juanjuan; Tan, Minjie; Zhu, Jing; Tian, Ye; Liu, Huanyu; Luo, Fan; Wang, Jianbin; Huang, Yanyi; Zhang, Yuanzhen; Yang, Yuexin; Wang, Guanbo
title: Proteomic analysis of human milk reveals nutritional and immune benefits in the colostrum from mothers with COVID-19
date: 2022-02-26
journal: bioRxiv
DOI: 10.1101/2022.02.25.481966
sha: 673a85be230b9f465de6fe4c04bbc8260189db78
doc_id: 1055387
cord_uid: n9bg2i98

The range of benefits breastfeeding provides neonates and infants include nutrition, improved neonatal survival, and reduced morbidity from certain diseases. It also aids maternal health by speeding postpartum recovery. However, due to concern about the risk of SARS-CoV-2 transmission and the lack of evidence of breastmilk’s protective effects against the virus, whether mothers with COVID-19 should be encouraged to breastfeed is under debate. Here, we present the results of proteomic and glycoproteomic studies of breast milk (colostrum and mature milk) from mothers with confirmed COVID-19. All colostrum samples exhibited significantly upregulated immune-related proteins, especially whey proteins with antiviral properties against SARS-CoV-2, and increased glycosylation levels and heterogeneity at those proteins. Such adaptive differences in milk from COVID-19 mothers tend to fade in mature milk from the same mothers one month postpartum. These results suggest the immune benefits of colostrum from mothers with COVID-19 and provide molecular-level insights that aid breastmilk feeding decisions in cases of active infection.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused over 171 million confirmed cases of coronavirus disease 2019 (COVID- 19) , which has resulted in over 3 million deaths globally as of June 2, 2021 1 .

Based on data from the United States, approximately 98,948 pregnant women had confirmed infections from January 22 to June 28, 2021, 0.14% of all COVID-19 cases. A systematic evidence review that followed the procedures in the Cochrane handbook for systematic reviews of interventions, identified studies that included mothers with suspected or confirmed COVID- 19 . As a result, in January 2021 the World Health Organization (WHO) updated their Interim Guidance on Clinical Management of COVID-19 to recommend that mothers with suspected or confirmed COVID-19 be encouraged to initiate and continue breastfeeding 2 .

However, concerns over the risk of viral transmission from mother to infant have inevitably hindered the choice to breastfeed. A three-month study in 2020 reported that the breastfeeding rate of infants under one week of age by mothers with COVID-19 was 8.8% in China 3 .

Breastmilk contains not only basic nutrients but also developmental immune system factors (e.g., antibacterial components, immunoglobulins, and immune cells) that help protect newborns from environmental pathogens. Tromp et al. (2017) found that breastfeeding was associated with a 30% reduction in lower respiratory tract infections in young children 4 . A member of the enveloped single-stranded RNA virus family, SARS-CoV-2 infects human bronchial epithelial cells, pneumocytes, and upper respiratory tract cells, and that can then lead to severe, life-threatening respiratory disease and lung injury 5 . Respiratory mucosal immunity with IgA, especially secretory IgA (sIgA), plays a major role in mounting an antiviral defense 6 . As the dominant antibody in milk, sIgA has a stronger protective effect than do IgGs because it can directly neutralize the virus while not activating the complement to cause inflammation 7 . The protection of breastfeeding against respiratory infections in infants is generally recognized 8 , and breast milk is an important sIgA source. However, the immune benefits of feeding breastmilk from mothers with COVID-19 remains elusive because of a lack of molecularlevel characterization of that milk.

In this work, we used mass spectrometry (MS)-based proteomic analysis to characterize the immune-related proteins in breast milk collected from both six COVID-19 patients and ten healthy donors and then compared the results from those two groups. Both colostrum and mature milk were examined to monitor dynamic proteomic changes. Most human milk proteins are glycosylated and the glycosylation pattern importantly aids in morbidity reduction 9 by both affecting proteolytic susceptibility 10 and serving as immunomodulators 11 and competitive inhibitors of pathogen binding 11, 12 . Therefore, we expanded the scope of this study to the glycoproteomic level by thoroughly characterizing a panel of key immune-related proteins' glycosylation patterns to reveal the COVID-19-induced dynamic glycoproteome evolvement. We show that combined proteomic and glycoproteomic strategies can provide straightforward nutrition and immunity information that can help professionals recommend appropriate infant feeding procedures for infected mothers.

The basic clinical characteristics between the patient group and control group were not significantly different (p＞0.05, Table 1 ). Based on the results of nested RT-PCR methods 13 , all milk samples tested negative for SARS-CoV-2, which ruled out the risk of direct viral transmission through the milk. Also, milk is recognized to be mature after 16 days postpartum and completely mature by 4 to 6 weeks postpartum 14 . Meanwhile, the protein content in human milk gradually decreases throughout lactation, but the rate of decrease is much lower at the fully mature stage 15 and the composition remains relatively consistent 14 . Therefore, the mature milk samples collected in this study represent a relative stable lactational period ( Figure 1A ). We conducted proteomic and glycoproteomic analyses of milk compositional changes in four sample groups: colostrum samples from COVID-19 patients (COVID-19 colostrum, n = 6) and from healthy donors (Ctrl colostrum, n = 10), and mature milk samples from COVID-19 patients (COVID-19 mature, n = 6) and from healthy donors (Ctrl mature, n = 10) ( Figure 1B ). Of the 1573 proteins identified in the four milk groups, 1439 were sufficiently abundant to be quantitatively monitored, and 1123 of those (78%) were shared by all groups (Figure 2A , Table S1 ). Principal components analysis (PCA) suggested a distinction between the COVID-19 colostrum group and the other three groups,

indicating an alteration in milk proteome upon active SARS-CoV-2 infection ( Figure 2B ). The total protein content in the COVID-19 colostrum group were 4.1 times higher than that in the control colostrum group;

particularly, casein proteins were 3.9 times lower and whey proteins were 7.2 times higher ( Figure 2C ). As the major components of milk, whey proteins and caseins (comprising about 45%-97% and 3%-55% of human milk proteins, respectively) figure importantly in nutrition and immunity 16 , including being sources of amino acids, enhancing micronutrient bioavailability, providing immunogenic training for innate and adaptive immunity, and promoting intestinal growth and maturation via interactions with the microbiome 17 . The proportion of casein proteins in the COVID-19 colostrum group was lower than that of the other groups (p < 0.0001; Figure 2C ), likely because of the downregulation of all caseins (α-S1-, β-, κ-caseins) and an increase in the total abundance of whey proteins. In detail, Among the highly abundant milk proteins, beta-casein and immunoglobulins (predominated by sIgA1) were significantly down-and upregulated, respectively ( Figure 2D ).

The differences between COVID-19 milk and Ctrl milk protein contents at the mature stage were not significant ( Figure 2C and 2D). Upregulation of immune-related proteins suggest the adaptive immune benefit of colostrum from COVID-

In comparing the COVID-19 colostrum and Ctrl colostrum groups (cut-off p < 0.05 and fold change >2), we found 282 upregulated proteins and 58 downregulated proteins ( Figure 2E ) in association with 34 and 7 enriched biological processes, respectively, among which we specify the most prominent ones in Figure 2F (see Table S2 for the list of enriched GO terms and their related proteins). The increased expressions of immunoglobulins in response to the viral infection served as the major contributors to those term groups. We did not directly measure sIgA because of the bottom-up approach used in this study. Consider that the intact multimeric form of sIgA incorporates IgA1/IgA2, a joining chain (JC), and a secretory component from the endoproteolytic cleavage of the polymeric immunoglobulin receptor (PIGR) 18 . So, since JC, PIGR, light chains, and variable regions may be used to assemble other forms of immunoglobulins, we instead used the detected quantities of immunoglobulin heavy constant A1 and A2 (IGHA1 and IGHA2) to represent the abundances of sIgA1 and sIgA2. Notably, ribosomal proteins were among the significantly downregulated proteins and they contributed to the GO term for both ribosomal large subunit assembly and protein localization establishment to the endoplasmic reticulum (ER, Figure 2F ), both of which are activities associated with viral replication and transport.

Biological pathway analysis revealed 15 differentially expressed proteins that participate in the pathway related to coronavirus disease. Nine ribosomal proteins that might inhibit protein expression in the mammary gland were down-regulated, while some complement proteins (e.g., complement factor B, complement C3, and complement C4B) increased. Altogether, the proteome in COVID-19 colostrum featured a much higher proportion of immunoglobulins than did that of the Ctrl colostrum, thus implying that the former likely provides infants adaptive immune protection against coronavirus.

Glycoprotein microheterogeneity originates from the various glycan structures that may attach to identical glycosylation sites on cell surfaces. Because microheterogeneity leads to differing preferences of glycan-based interactions and reorganization of dynamic epitopes 19 , it thus facilitates virus neutralization. Our glycoproteomic measurements identified 820 unique N-glycopeptides from 48 different glycoproteins ( Figure   3A ), results that mostly agreed with those of a previous study 20 . Most of those glycoproteins were within the top 200 most abundant milk proteins ( Figure S1A ). Also, most of them had one to six identified glycosites, but tenascin (TNC), which is involved in protection against viral infections 21 , had 12 glycosites ( Figure S1B ). In the COVID-19 colostrum glycoproteome, we observed a high degree of microheterogeneity ( Figure S1C ) that was clearly distinct from those of the other three samples groups ( Figure 3B ). Among 103 glycosites, 66.0% had more than 1 glycoform and 18.4% harbored more than 10 glycoforms. Taking the glycosylation pattern into account, we detected only 178 (21.7%) of the 820 glycopeptides in all sample groups, while 33.2% (272) of the glycopeptides were detected exclusively in the COVID-19 colostrum group ( Figure 3A ). This was most likely 8 because of a dramatically improved glycosylation pattern diversity and slightly increased number of glycosites in that group ( Figure S1D ) rather than more protein identities ( Figure S1E ). We observed 83 upregulated and 17 downregulated N-glycopeptides, as well as site-specific N-glycosylation changes, in the COVID-19 colostrum ( Figure S2 ). As the major components in milk, the two most abundant glycoproteins, lactoferrin (LTF) and sIgA1, exhibited different glycosylation pattern alteration trends in response to COVID-19. The elevated level of sIgA, a key component in adaptive immunity, was accompanied by increases in both microheterogeneity at IGHA1's Asn144, and Asn340 N-glycosylation sites and those glycoforms' expression levels ( Figure 3C ). In contrast, LTF, which is associated with innate immunity 22 , showed reduced microheterogeneity ( Figure 3D ).

Compared to levels in the COVID-19 colostrum, the proportions of whey proteins, especially sIgA1, decreased significantly in the COVID-19 mature group ( Figure 2C and 2D ). Besides the overlapping proteins that were differentially expressed at different lactational stages in the Ctrl groups, 201 proteins were downregulated while 83 proteins were upregulated in COVID-19 milk during its maturation ( Figure S3A ). Fourteen and eight biological processes changed significantly for down-and up-regulated proteins, respectively (Table S3 , Figure   S3B ). Leukocyte mediated immunity, adaptive immune response, and complement activations involved the largest number of down-regulated proteins, and phagocytosis recognition and regulation of complement activation involved the highest proportion of all associated genes. Up-regulated proteins during maturation were clustered largely in the SRP-dependent co-translational protein targeting membrane and ubiquitin ligase inhibitor activity GO terms. Also, multiple ribosomal proteins contributed to those clusters. The downregulated proteins clearly show that immune-related proteins had obviously decreased during the mature milk phase and with the COVID-19 patients' recoveries.

The COVID-19 colostrum's unique glycosylation features also appeared to fade with milk maturation. Seven Nglycopeptides were back-upregulated and 55 were back-downregulated in the COVID-19 mature sample group ( Figure S4A ). The glycosite-specific changes at sIgA and LTF in COVID-19 colostrum, with respect to Ctrl groups, underwent reverse evolvement in the COVID-19 mature group, producing glycosylation patterns that were similar to those of the Ctrl mature milk ( Figure S4B ). Using the changes between Ctrl colostrum and Ctrl mature as the reference, sIgA's microheterogeneity and glycosylation levels at Asn144 and Asn340 changed more prominently than other IGHA1 N-glycopeptides did ( Figure S4C ), and so did LTF at Asn156, 497, and 642 ( Figure   S4D ). See Figure S5 for an extended list of N-glycoproteome site-specific changes between Ctrl colostrum and Ctrl mature groups. In summary, the proteome and glycoproteome profiles exhibited in the mature milk of the COVID-19 mature and Ctrl mature groups ( Figure 2B , 3B, S6A and S6B) were not substantially different.

In healthy mother-infant dyads, human milk provides nutritional and protective components for newborns facing pathogenic challenges 17 . During inflammation or infection in either mother 23 or infant 24 , the changes in breastmilk components not only reflects the maternal-infant health status 25, 26 , but also provides the neonate with protection from diseases ranging from diarrhea to acute respiratory tract infections 27 . However, since SARS-CoV-2 RNA has been detected in human breastmilk, women with COVID-19 are greatly concerned about feeding their infants breastmilk [28] [29] [30] [31] . Chinese experts have recommended that COVID-19 infected mothers delay breastfeeding for periods of up to two weeks after delivery 32 , and many patients chose to begin breastfeeding after recovery. Also, some hospitals are implementing practices that conflict with WHO's policy on the subject 33 . All infected mothers of newborns must understand the nutritional and immune benefits of breastmilk so they may knowledgeably consider the option of feeding it to their infants.

COVID-19 infection clearly leads to significant changes in profiles of both proteome and glycosylation patterns in breastmilk, and they both undergo dynamic evolution as milk maturation proceeds. Two major components 10 of human breastmilk, casein and whey proteins, are down-and up-regulated, respectively, and several studies have found that the composition of human breastmilk changes according to the infant's demands 34, 35 . Fetus oxygen is supplied completely through placental transport, and the most striking features of COVID-19

placentas are decidual arteriopathy and other maternal vascular malperfusion features, either one of which can cause fetal hypoxia 36 . Hypoxia in neonatal rats leads to delayed enzyme maturation in the small intestine, which is the main site for protein absorption. The activities of those enzymes returned to control levels 3 weeks after recovery 37 . Maternal stressors in late pregnancy can also impair the fetal gut, further limiting the ability of the newborn to absorb nutrients, especially proteins from colostrum 38 . Absorption of high-MW casein proteins is more difficult than absorption of relatively low-MW whey proteins. Given that COVID-19 neonates likely suffered fetal hypoxia and maternal stresses due to the disease, the decreased levels of casein proteins and increased whey protein abundance in COVID-19 colostrum benefits the neonatal gut's ability to effectively absorb milk proteins during the first few days postpartum. As the neonatal gut recovers from hypoxia damage, both casein and whey protein abundances return to normal levels in mature milk ( Figure 2C ). Since caseins in human milk provide essential amino acids 39 with IgG's transplacental protection that is most efficient against microbes in the blood and tissues and that functions through a complementary system that induces energy consumption and destructive tissue inflammation 49 . The major immunoglobulin in human milk, sIgA, serves as a first line defense in mucosal areas, using mechanisms that include intracellular neutralization, virus excretion, and immune exclusion 50, 51 . When a pathogen enters the mother's upper airways, the Peyer's patch acquires the pathogen and its antigens are presented by M cells to circulating B cells that then migrate to the serosal (basolateral) side of the mammary epithelial cell, and it produces IgAs. As the IgAs move from the serosal to the luminal (apical) side of the mammary epithelial cell, they are glycosylated and complexed to form sIgA, which is secreted into milk 17, 52 .

Since sIgA is more resistant to protein hydrolysis than IgG is, it can function on the mucosal membranes primarily in the gastrointestinal tract and to some extent in the respiratory tract as well 49 . Because the volume 11 of milk ingested increases as a neonate grows, sIgA, which usually occurs in higher concentrations in colostrum than in mature milk, is nevertheless maintained at a relatively constant total amount throughout lactation. On average, the proportion of sIgA1 in the milk proteins of COVID-19 colostrum was 8.6 times greater than in the Ctrl colostrum ( Figure 2D ), thus indicating that the mothers' responses to the infection and additional adaptive immunological protection for the infants from viruses may be introduced through the gastrointestinal or respiratory tract. Indeed, it has been reported that a portion of sIgA present in milk from COVID-19 patients were RBD-specific 53, 54 . Such protection may be further strengthened by other adaptive immunity-related proteins that appear in higher abundances in COVID-19 colostrum than in Ctrl colostrum ( Figure 2F ).

Ribosomal proteins are the major class of downregulated whey proteins in COVID-19 colostrum ( Figure 2F ), even with the increased total amount of whey proteins. Ribosomal proteins are essential for translating genetic information from mRNA into proteins 55 , and they dictate ribosomal large subunit assembly and the establishment of protein localization to the ER. Since SARS-CoV-2 has no cellular structure of its own, it can only replicate by utilizing ribosomes in infected cells to make viral polyprotein and then processing and transporting that polyprotein formed in ER ribosomes 56 . Downregulation of those ribosomal proteins in COVID-19 colostrum may be associated with the milk protein synthesis status that helps inhibit viral replication and viral polyprotein transport in the mammary glands of infected, lactating mothers.

The glycoproteins, especially immunoglobulins in COVID-19 colostrum, generally exhibit much higher degrees of glycan microheterogeneity (Figure 3 ), a feature that may help recognize more dynamic epitopes and favor different glycan-based interactions 19 . Consider that SARS-CoV-2 assembly and its attachment and entry to a host cell is closely related to its heavily glycosylated spike protein 57 , which has 22 occupied N-glycosylated sites 58 and diverse glycosylation 59 . Glycans at the surface of SARS-CoV-2 are essential for viral entry, as shown in vitro when blocked N-glycan biosynthesis at the oligomannose stage dramatically reduced viral entry into HEK293T cells 60 . When SARS-CoV-2 enters the human body, it first recognizes sialic acid and searches for its receptor. Next, very likely the viral envelope glycans interact with sialic acid-binding lectins that are expressed in a host cell-dependent manner 61 . Accordingly, the more that human milk glycoproteins have glycan microheterogeneity, the better their ability might be to interact with SARS-CoV-2 via multiple glycan-based molecular events in the infants' gastrointestinal tract. That then helps block SARS-CoV-2 binding to its receptor, ACE2, on the cell surface.

The WHO's breastfeeding recommendations for COVID-19 mothers are largely based on both the significant consequences of not breastfeeding and the separation between mother and child, as well as on the low risk of vertical transmission of COVID-19 through breastfeeding. Here, the proteomic and glycoproteomic data suggest the nutritional and immune benefits of breastmilk feeding at the molecular level. Since all prominent differences between COVID-19 and Ctrl colostrum proteomes, in terms of the casein/whey ratio, differently expressed proteins and the related significantly enriched biological processes, and the microheterogeneity of glycosylation all fade as milk maturation proceeds, those benefits may be attenuated by delaying breastmilk 12 feeding. Based on the premise that contact transmission between COVID-19 mothers and their newborns is prevented, our results provide helpful information for selection of approaches to lactation.

Human milk samples were collected from six patients with confirmed COVID-19 and from ten healthy donors.

First, colostrum samples were collected within 3-4 days post-partum, and then mature milk samples were 

The in-solution digestion of whole milk was adapted from previous methods 62 . Briefly, a 20 μl milk sample was added to 80 μl of protein lysis buffer (ThermoFisher, USA) with a protease inhibitor (ThermoFisher, USA). The whole milk buffer was sonicated 20 mins in a water bath with cold water and put on ice for another 30 mins.

Impurities were removed by methanol/chloroform protein precipitation and the precipitate was air dried. The Byonic version 3.10.2 (Protein Metrics Inc.) was used to search the glycoproteomic data against the previously determined targeted milk protein database (1573 entries). The search was based on the above-mentioned shotgun proteome analysis strategy and used the following search parameters: trypsin digestion with a maximum of three missed cleavages; 10 ppm precursor ion mass tolerance; fragmentation type, HCD for stepped HCD files and EThcD for EThcD files; 20 ppm fragment mass tolerance; cysteine carbamidomethylation as a fixed modification; Met oxidation and acetylation at the peptide N-terminus as variable modifications. For glycan analysis, we used a Byonic database of 132 human glycan entries. The maximum number of precursors per scan was set to one and the FDR to 1%. Only PSMs to the EThcD spectra or more than two PSMs to the HCD spectra, both with non-negligible error probabilities |log Prob|>2.0 and Byonic scores ≥200, were accepted. The total number of spectra counts for each glycopeptide was used as the quantified value for further analysis.

All statistical analyses were performed using SPSS 21.0 (SPSS Inc., Chicago, IL, USA), Perseus v.1.6.14.0 65 , or under the R Statistical Computing Environment (v. 4.0.2). The Mann-Whitney U-test was used to assess differences in skewed data. The Fisher's exact probability method was used to test the categorical variables, and one-way analysis of variance or Student's t-test were used to compare the differences in normally distributed data. Principal component analysis and plots were used to conduct data reduction and to visualize the differences in all samples. Statistical significance for all tests was P < 0.05. Proteins with an adjusted p-value<0.05 were considered to have undergone significant protein enrichment. For identification of up and down-regulated proteins, a Cytoscape (v3.6.0) App ClueGOwas 66 used based on the terms "biological processes" in the human database. Statistical significance was set for a K score of 0.8. The function "GO Term fusion" was selected and GO term restriction levels were set at 1-20, with a minimum of two proteins or 4% proteins in each GO term.

The proteome data (dataset identifier PXD024776) have been deposited to the ProteomeXchange Consortium 

Memory CD4(+) T cells are generated in the human fetal intestine

COVID-19 clinical management: living guidance

Impact of Covid-19 in pregnancy on mother's psychological status and infant's neurobehavioral development: a longitudinal cohort study in China

Breastfeeding and the risk of respiratory tract infections after infancy: The Generation R Study

Coronavirus biology and replication: implications for SARS-CoV-2

Structure and function relationships in IgA

Systematic comparison of respiratory syncytial virus-induced memory B cell responses in two anatomical compartments

Full breastfeeding duration and associated decrease in respiratory tract infection in US children

Functional glycans and glycoconjugates in human milk

Role of N-glycosylation in cell surface expression and protection against proteolysis of the intestinal anion exchanger SLC26A3

Human milk glycoproteins protect infants against human pathogens

The Role of Human Milk Immunomodulators in Protecting Against Viral Bronchiolitis and Development of Chronic Wheezing Illness

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Human milk composition: nutrients and bioactive factors

Longitudinal evolution of true protein, amino acids and bioactive proteins in breast milk: a developmental perspective

Absolute Quantification of Human Milk Caseins and the Whey/Casein Ratio during the First Year of Lactation

The Functional Power of the Human Milk Proteome

Role of J chain in secretory immunoglobulin formation

Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16

Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes

Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk

Lactoferrin, a versatile natural antimicrobial glycoprotein that modulates the host's innate immunity

Inflammatory breast diseases during lactation: health effects on the newborn-a literature review

Changes in immunomodulatory constituents of human milk in response to active infection in the nursing infant

Changes over lactation in breast milk serum proteins involved in the maturation of immune and digestive system of the infant

Temporal changes in milk proteomes reveal developing milk functions

Protective effects of breastfeeding against acute respiratory tract infections and diarrhoea: Findings of a cohort study

Detection of SARS-CoV-2 in human breastmilk

Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19)

Excretion of SARS-CoV-2 in human breast milk. Clinical microbiology and infection : the official publication of the European Society of

Breastfeeding Risk from Detectable Severe Acute Respiratory Syndrome Coronavirus 2 in Breastmilk

Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection

Implementation of Hospital Practices Supportive of Breastfeeding in the Context of COVID-19 -United States

In poor families, mothers' milk is richer for daughters than sons: a test of Trivers-Willard hypothesis in agropastoral settlements in Northern Kenya

Variation in macronutrients in human bank milk: influencing factors and implications for human milk banking

Placental Pathology in COVID-19

Effects of hypoxia on the development of intestinal enzymes in neonatal and juvenile rats

Gut health, stress, and immunity in neonatal dairy calves: the host side of host-pathogen interactions

Human milk proteins: key components for the biological activity of human milk

Bioactive Proteins in Human Milk: Health, Nutrition, and Implications for Infant Formulas

Monitoring Human Milk β-Casein Phosphorylation and O-Glycosylation Over Lactation Reveals Distinct Differences between the Proteome and Endogenous Peptidome

The effect of whey protein on viral infection and replication of SARS-CoV-2 and pangolin coronavirus in vitro

The mucosal immune system and its integration with the mammary glands

Modulation of the gastrointestinal tract of infants by human milk. Interfaces and interactions. An evolutionary perspective

High-resolution longitudinal serum proteome trajectories in COVID-19 reveal patients-specific seroconversion

Human Milk from Previously COVID-19-Infected Mothers: The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity

Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19

Perspectives on immunoglobulins in colostrum and milk

The role of breastfeeding in prevention of neonatal infection

Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut

Transfer of antibody via mother's milk

Innate immunity and human milk

Robust and Specific Secretory IgA Against SARS-CoV-2 Detected in Human Milk

Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2

Regulatory Nucleotide Sequence Signals for Expression of the Genes Encoding Ribosomal Proteins. Frontiers in genetics 11

Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome

The Importance of Glycans of Viral and Host Proteins in Enveloped Virus Infection

Site-specific glycan analysis of the SARS-CoV-2 spike

Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition

Inhibition of SARS-CoV-2 viral entry upon blocking N-and O-glycan elaboration

Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects

Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Top-Down Mass Spectrometry

UniProt: a worldwide hub of protein knowledge

Critical assessment of proteome-wide label-free absolute abundance estimation strategies

The Perseus computational platform for comprehensive analysis of (prote)omics data

Comprehensive functional analysis of large lists of genes and proteins

The authors declare no competing interests.